Overview

Dronabinol On the Pain Experience

Status:
Not yet recruiting

Trial end date:
2023-12-31

Target enrollment:

Participant gender:

Summary

The purpose of this study is to identify the effect dronabinol has on opioid exposure when used as an adjunct to the current standard multi-modal pain regimen (MMPR)

Phase:

Phase 4

Details

Lead Sponsor:

The University of Texas Health Science Center, Houston

Collaborator:

The Eastern Association for the Surgery of Trauma

Treatments:

Dronabinol